FREE Stock Alerts By Email!
~~~~~~~~~~~~~~~~~~~~~~~~~~
FROI,
BOCL and WZE!!!
~~~~~~~~~~~~~~~~~~~~~~~~~~
FROI - Fero Industries, Inc.
FROI just hit a new 52 week high of .67 on 4x its average daily volume.
FROI is
shaping up exactly how we thought it would. If
FROI continues to move to new highs
and starts getting traction it could have a nice breakout increasing its price per
share substantially. We are looking for that type of move relatively soon.
About Pyro Pharmaceuticals, Inc.
Pyro Pharmaceuticals, Inc. is developing therapeutics against multi-drug resistant
infectious microorganisms or "Super Bugs." Pyro`s focus is on diseases in which
antibiotic resistance has become a significant issue. Pyro`s plan is to develop
a new class of antibiotics for a wide variety of disease causing microorganisms,
especially those that have exhibited multiple drug resistance. Antibiotic resistance
is a growing public health concern worldwide. According to the Center for Disease
Control ("CDC"), antibiotic drug resistance has significantly increased mortality
rates, making infectious disease the third largest cause of death in the United
States. Drug resistance has also increased the cost of health care delivery. Examples
of the types of bacteria that have become resistant to antibiotics include the species
that cause skin infections, meningitis, sexually transmitted diseases, respiratory
tract infections such as pneumonia and tuberculosis, and multi-drug resistant Staphylococcus
aureus (
MRSA).
Pyro is a development stage company. Its plans and businesses are "proposed" and
"intended," but it may not be able to successfully implement them with without
funding. In addition, Pyro has not earned revenues and has incurred losses since
its incorporation. As a development stage company, Pyro`s prospects are subject
to all of the risks, expenses, and uncertainties frequently encountered by companies
in the drug development and pharmaceutical business.
Recent news:
9:00 am EST, Tuesday November 10, 2009
Pyro Pharmaceuticals, Inc. Announces the Appointment of Robert C. Moellering, Jr.,
M.D. as Chairman of the Scientific Advisory Board
9:00 am EDT, Monday October 26, 2009
Pyro Pharmaceuticals, Inc. Discloses Information on its Ten Patent Applications
9:00 am EDT, Wednesday October 21, 2009
Fero Industries, Inc. Acquisition Target, Pyro Pharmaceuticals Appoints New Board
Member
~~~~~~~~~~~~~~~~~~~~~~~~~~
~~~~~~~~~~~~~~~~~~~~~~~~~~
See Red Hot Penny Stock's website for full disclaimer. Red Hot Penny Stock may have received compensation for stock picks.
home
